Lymphatic vessel density is significantly increased in melanoma

Journal of Cutaneous Pathology

Volumn 31, Issue 10, 2004, Pages 672-677

  Giorgadze, T A ^a   Zhang, P J ^a   Pasha, T ^a   Coogan, P S ^b   Acs, G ^a   Elder, D E ^a   Xu, Xiaowei ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; DYSPLASTIC NEVUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MELANOMA; NEVUS; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; BIOLOGICAL MARKERS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC VESSELS; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; NEVUS; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 7444235486     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00249.x     Document Type: Article

References (24)

1. Streit M, Detmar M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene 2003; 22: 172.
2. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001; 7: 462.
3. Shellman YG, Park YL, Marr DG, et al. Release of vascular endothelial growth factor from a human melanoma cell line, WM35, is induced by hypoxia but not ultraviolet radiation and is potentiated by activated Ras mutation. J Invest Dermatol 2003; 121: 910.
4. Skobe M, Hamberg LM, Hawighorst T, et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001; 159: 893.
5. Sleeman JP, Krishnan J, Kirkin V, Baumann P. Markers for lymphatic endothelium: in search of the Holy Grail? Microsc Res Tech 2001; 55: 61.
6. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion of primary tumors. Lab Invest 2002; 82: 1255.
7. De Waal RMW, van Altena MC, Erhard E, Weidle UH, Nooijen PTGA, Ruiter DJ. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am J Pathol 1997; 150: 1951.
8. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250.
9. Dadras DD, Paul T, Bertonchini J, et al. Tumor lymphangiogenesis. A novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003; 162: 1951.
10. Fox SB. Tumor angiogenesis and prognosis. Histopathology 1997; 30: 294.
11. Valcovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive breast carcinoma. Virchows Arch 2002; 440: 583.
12. Gasinska A, Urbanski K, Adamezyk A, Pudelek J, Lind BK, Brahme A. Prognostic significance of intratumoral microvessel density and hemoglobin level in carcinoma of uterine cervix. Acta Oncol 2002; 41: 437.
13. Tanigava N, Amaya H, Matsumura M, et al. Tumor angiogenesis in patients with colorectal cancer. Cancer Res 1997; 57: 1043.
14. Matsuyama K, Chiba Y, Sasaki M, Tanaka H, Muraoka R, Tanigava N. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Ann Thorac Surg 1998; 65: 1405.
15. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902.
16. Erhard H, Rietveld FJR, van Altena MC, et al. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis. Melanoma Res 1997; 7 (Suppl. 2): S19.
17. Achen MG, Williams RA, Minekus MP, et al. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J Pathol 2001; 193: 147.
18. Straume O, Akslen LA. Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanoma. Am J Pathol 2001; 159: 223.
19. Straume O, Akslen LA. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. Am J Pathol 2002; 160: 1009.
20. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988; 133: 419.
21. Graham CH, Rivers J, Kerbel RS, Stanliecz KS, White WL. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 1994; 145: 510.
22. Barnhill RL, Fandrey K, Levy MA, Mihm MC, Hyman B. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 1992; 67: 331.
23. Busam KJ, Berwick M, Blessing K. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995; 147: 1049.
24. Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR III. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 2002; 20: 1826.